Alopecia areata is a disease that happens when the immune system attacks hair follicles and causes hair loss. While hair can be lost from any part of the body, alopecia areata usually affects the head and face.
This sponsored webinar explores the unique product characteristics of different botulinum toxin type A (BoNT/A) products and the clinical implications of these differences.
As part of AMCP Foundation's efforts to train managed care pharmacists in specialized care practices, Raquel Erb, a PharmD candidate at the University of Texas at Austin, College of Pharmacy, completed our inaugural internship sponsored by Sanofi, studying and optimizing the benefit design of specialty drugs.
This sponsored webinar provides an overview of the patient journey to treatment and discusses signs and diagnosis of early Alzheimer's Disease, the clinical trial data in informing selection for treatment for appropriate patients, key considerations for initiating the treatment, and monitoring for safety.
JMCP’s Editor-in-Chief shares three reasons to check out JMCP’s new website, including the Managed Care Pharmacy Primer Series, timely papers on implementation of the IRA, and JMCP’s policy on AI.
By Laura E. Happe, PharmD, MPH, Editor-in-Chief, JMCP • 12/6/23
The AMCP Health Disparities Advisory Group conducted a landscape assessment to understand the role of managed care pharmacy in identifying and addressing health care disparities. Explore their findings and discover opportunities to dismantle inherent health disparities by downloading the assessment.
On October 4, 2023, the Department of Health and Human Services, the Department of Labor, and the Department of the Treasury issued a request for information titled “Coverage of Over-the-Counter Preventive Services”. This request is regarding the application of the preventive services requirements under the Public Health Service Act to over-the-counter (OTC) preventive items and services available without a prescription by a health care provider. Some examples could include certain types of tobacco cessation pharmacotherapy, folic acid supplements, breastfeeding supplies, and contraceptives such as a recently approved OTC progestin-only daily oral contraceptive. Additional recommended preventive products may become available OTC in the future. AMCP submitted comments in response to the proposed rule on December 4, 2023.